Redpoint Investment Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-28,663
Closed -$688K 592
2019
Q2
$688K Sell
28,663
-50,783
-64% -$1.5M 0.04% 416
2019
Q1
$2.95M Sell
79,446
-2,569
-3% -$93.5K 0.15% 177
2018
Q4
$2.31M Sell
82,015
-8,885
-10% -$281K 0.14% 198
2018
Q3
$3.58M Hold
90,900
0.18% 149
2018
Q2
$4.03M Buy
90,900
+81,790
+898% +$4.07M 0.22% 121
2018
Q1
$444K Buy
9,110
+2,813
+45% +$141K 0.02% 418
2017
Q4
$315K Buy
+6,297
New +$330K 0.02% 447

Other funds holding CC

Redpoint Investment Management's CC Position: Q3 2019 in Review

Redpoint Investment Management sold out of Chemours (CC) in Q3 2019, closing a stake of 28,663 shares — an estimated $688K sold.

Redpoint Investment Management first reported a position in CC in Q4 2017 and held it in 7 quarters. The position peaked at $4.03M in Q2 2018. 418 funds tracked by Wall St. Rank hold CC as of Q3 2019.

  • Redpoint Investment Management reported no remaining Chemours position as of Q3 2019 after selling out during the quarter.
  • Redpoint Investment Management sold 28,663 Chemours shares in Q3 2019, an estimated $688K.
  • Redpoint Investment Management first reported a position in Chemours in Q4 2017 and held it in 7 quarters.
  • Redpoint Investment Management's Chemours position peaked at $4.03M in Q2 2018.
  • 418 funds tracked by Wall St. Rank held Chemours as of Q3 2019.

Based on Redpoint Investment Management's 13F filing for Q3 2019, filed 26 Nov 2019.